ID4157 Bc AR 2007 Insides 80pp 04. qxp 6 3 08 15:20 Page 78 Notes to the Company Financial Statements Year ended 31 December 2007 1. profit for the year As permitted under section 230 of the Companies Act 1985 the Company has elected not to present its own profit and loss account for the year.
Bodycote International plc reported a profit for the financial year ended 31 December 2007 of 1.5m 2006: 53.0m.
The auditors remuneration for audit services to the Company was 0.1m 2006: 0.1m.
Total employee costs including Executive Directors were: 2007 2006 m m Wages and salaries 4.6 4.5 Social security costs 0.5 0.4 Other pension costs 0.3 0.2 5.4 5.1 2.
Tangible Fixed Assets Fixtures and ttings m Cost At 1 January 2007 1.0 Additions 0.5 At 31 December 2007 1.5 Depreciation At 1 January 2007 0.4 Charge for the year 0.1 At 31 December 2007 0.5 Net book value At 31 December 2007 1.0 At 31 December 2006 0.6 78 Bodycote annual report 2007 ID4157 Bc AR 2007 Insides 80pp 04. qxp 6 3 08 15:20 Page 79 3.
Investments Shares in Shares associates Loans Total m m m m Cost 1 January 2007 401.0 7.3 457.0 865.3 Acquisitions and advances 2.7.
457.0 849.4 Shares in associates comprise: Name of company Nature of Country of % Holding of business incorporation ordinary shares SSCP Coating S.. r. l. PVD Coatings Luxembourg 24 4.
Debtors 2007 2006 m m Amounts falling due within one year: Amounts owed by subsidiary undertakings 4.1 10.4 Corporation tax recoverable 0.4 2.6 Deferred taxation 3.3 1.2 Finance lease receivables 0.4 0.4 Derivative financial instruments.
1.9 Other debtors and prepayments 1.8 2.8 10.0 19.3 Amounts falling due after more than one year: Amounts owed by subsidiary undertakings 30.8.
Finance lease receivables 1.1 1.5 Derivative financial instruments.
0.6 Other debtors 8.8 5.8 40.7 7.9 50.7 27.2 Bodycote annual report 2007 79 ID4157 Bc AR 2007 Insides 80pp 04. qxp 6 3 08 15:20 Page 80 Notes to the Company Financial Statements Year ended 31 December 2007 5.
Creditors 2007 2006 m m Amounts falling due within one year: Bank loans.
2.0 Bank overdrafts 8.5 5.0 Trade creditors 0.3 1.1 Amounts owed to subsidiary undertakings 1.4 0.5 Dividends payable 8.8 8.0 Other taxes and social security 0.1 0.2 Derivative financial instruments.
0.2 Other creditors 0.5 0.7 Accruals and deferred income 1.6 1.0 21.2 18.7 Amounts falling due after more than one year: Bank loans.
183.4 Amounts owed to subsidiary undertakings 67.6 289.8 Derivative financial instruments.
0.1 Other creditors 0.1 0.2 67.7 473.5 Bank loans are repayable: After 5 years.
140.3 Between 1 and 2 years... 183.4 On demand or within 12 months.
Deferred taxation Deferred tax m At 1 January 2007 1.2 profit and loss credit 0.2 Reclassication from corporation tax recoverable 1.9 At 31 December 2007 3.3 Deferred tax 2007 2006 m m Deferred tax is recognised provided as follows: Accelerated capital allowances.
Other timing differences 1.4 1.3 Deferred tax asset 3.3 1.2 80 Bodycote annual report 2007 ID4157 Bc AR 2007 Insides 80pp 04. qxp 6 3 08 15:20 Page 81 7.
Capital and reserves Share capital: 2007 2006 m m Authorised 430,000,000 2006: 430,000,000 ordinary shares of 10p each 43.0 43.0 Allotted, called-up and fully paid 323,673,223 2006: 322,168,062 ordinary shares of 10p each 32.4 32.2 Details of share options in issue on the Companys share capital and share-based payments are set out in note 28 to the group financial statements.
Reserves: Share profit premium Other and loss account reserves account Total m m m m At 1 January 2007 302.1 4.5 46.3 352.9 Dividends paid.. 23.4 23.4 profit for the year.. 1.5 1.5 Bonus issue of debentures.. 30.0 30.0 Reclassication.
Premium arising on issue of equity shares net of expenses 2.9.. 2.9 Share based payments and acquisition of own shares.
6.7 At 31 December 2007 305.0 6.9 59.1 357.2 The other reserve is stated after deducting 7.3m 2006: 2.4m relating to shares held in the Bodycote International Employee benefit Trust and 3.7m 2006: nil relating to shares held in treasury.
The Bodycote International Employee benefit Trust holds Bodycote International plc shares and satisfies awards made under various employee incentive schemes when issuance of new shares is not appropriate.
At 31 December 2007 3,112,931 2006: 1,235,110 shares were held by the Bodycote International Employee benefit Trust and following recommendations by the employer are provisionally allocated to satisfy awards under employee incentive schemes.
The trust waives payment of dividend.
The market value of these was 5.8m 2006: 2.8m.
At 31 December 2007 2,025,000 2006: nil shares were held in treasury.
The market value of these was 3.8m 2006: nil.
On 25 June 2007 Bodycote European Holdings Limited, a wholly owned subsidiary of the Company, created and issued to Bodycote International plc 30m of debenture securities redeemable not later than 25 June 2012.
Contingent liabilities The company has guaranteed bank overdrafts and loans of certain subsidiary undertakings amounting to 225.6m 2006: 3.1m.
Pension commitments The Company participates in a group dened benefit scheme, the details of which are disclosed in note 29 to the group financial statements.
However, the Company is unable to identify its share of the underlying assets and liabilities and has therefore accounted for the scheme as if it were a dened contribution scheme.
Full disclosures concerning the scheme as required by IAS 19 are set out in note 29 to the group financial statements.
Bodycote annual report 2007 81 ID4157 Bc AR 2007 Insides 80pp 04. qxp 6 3 08 15:20 Page 82 Notes to the Company Financial Statements Year ended 31 December 2007 10.
Derivative financial instruments Forward foreign exchange derivative contracts The Company utilises forward foreign exchange derivatives to hedge material future transactions and cash ow.
The Group uses foreign currency forward contracts in the management of its exchange rate exposures.
The contracts are primarily denominated in the currencies of the groups principal markets and currency interest ows.
The unrecognised gains and losses were not material in either 2007 or 2006.
Cross currency swaps During the year the Company entered into foreign currency denominated cross currency swaps that were designated as a hedging instrument for the purposes of hedging the translation of its foreign operations.
These contracts are entered into either with both currencies at oating interest rates generally based on 3 month LIBOR interest rates or both currencies at xed interest rates.
During the year the cross currency swap contracts of the Company were novated to Bodycote Finance Limited, a wholly owned subsidiary of the Company.
Interest rate derivatives The Companys interest rate risk is primarily in relation to its xed rate borrowings fair value risk and oating rate borrowings cash ow risk.
From time to time the Company may use interest rate derivative contracts to manage its exposure to interest rate movements within Group policy.
However at the balance sheet date the Company had no interest rate derivative contracts.
Full disclosure of the fair value of derivative financial instruments are set out in note 18 to the group financial statements.
Related party transactions During the year, the company entered into the following transactions with related parties who are not members of the Group: Sale of goods and services Amounts owed by related parties 2007 2006 2007 2006 m m m m Associates 1.3 0.8 12.0 8.0 Sales of goods and services include payments received from finance leases, the provision of management services and interest receivable.
All transactions were made at arms length.
The amounts outstanding will be settled in cash, of which 0.8m is secured.
No guarantees have been given or received.
1.1m of provisions have been made for doubtful debts and expensed during the year in respect of the amounts owed by related parties.
